Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 45

1.

Oral Vancomycin Prophylaxis as Secondary Prevention Against Clostridioides difficile Infection in the Hematopoietic Stem Cell Transplantation and Hematologic Malignancy Population.

Morrisette T, Van Matre AG, Miller MA, Mueller SW, Bajrovic V, Abidi MZ, Benamu E, Kaiser JN, Barber GR, Chase S, Tobin J, Fish DN, Gutman JA.

Biol Blood Marrow Transplant. 2019 Jun 27. pii: S1083-8791(19)30405-7. doi: 10.1016/j.bbmt.2019.06.021. [Epub ahead of print]

PMID:
31255741
2.

Addition of sirolimus to standard cyclosporine plus mycophenolate mofetil-based graft-versus-host disease prophylaxis for patients after unrelated non-myeloablative haemopoietic stem cell transplantation: a multicentre, randomised, phase 3 trial.

Sandmaier BM, Kornblit B, Storer BE, Olesen G, Maris MB, Langston AA, Gutman JA, Petersen SL, Chauncey TR, Bethge WA, Pulsipher MA, Woolfrey AE, Mielcarek M, Martin PJ, Appelbaum FR, Flowers MED, Maloney DG, Storb R.

Lancet Haematol. 2019 Aug;6(8):e409-e418. doi: 10.1016/S2352-3026(19)30088-2. Epub 2019 Jun 24.

PMID:
31248843
3.

Sequential azacitidine and lenalidomide for patients with relapsed and refractory acute myeloid leukemia: Clinical results and predictive modeling using computational analysis.

Stevens B, Winters A, Gutman JA, Fullerton A, Hemenway G, Schatz D, Miltgen N, Wei Q, Abbasi T, Vali S, Singh NK, Drusbosky L, Cogle CR, Hammes A, Abbott D, Jordan CT, Smith C, Pollyea DA.

Leuk Res. 2019 Jun;81:43-49. doi: 10.1016/j.leukres.2019.04.005. Epub 2019 Apr 13.

PMID:
31009835
4.

Venetoclax with azacitidine disrupts energy metabolism and targets leukemia stem cells in patients with acute myeloid leukemia.

Pollyea DA, Stevens BM, Jones CL, Winters A, Pei S, Minhajuddin M, D'Alessandro A, Culp-Hill R, Riemondy KA, Gillen AE, Hesselberth JR, Abbott D, Schatz D, Gutman JA, Purev E, Smith C, Jordan CT.

Nat Med. 2018 Dec;24(12):1859-1866. doi: 10.1038/s41591-018-0233-1. Epub 2018 Nov 12.

PMID:
30420752
5.

Thiotepa-Based Intensified Reduced-Intensity Conditioning Adult Double-Unit Cord Blood Hematopoietic Stem Cell Transplantation Results in Decreased Relapse Rate and Improved Survival Compared with Transplantation Following Standard Reduced-Intensity Conditioning: A Retrospective Cohort Comparison.

Sharma P, Pollyea DA, Smith CA, Purev E, Kamdar M, Haverkos B, Sherbenou D, Rabinovitch R, Hammes A, Gutman JA.

Biol Blood Marrow Transplant. 2018 Aug;24(8):1671-1677. doi: 10.1016/j.bbmt.2018.04.019. Epub 2018 Apr 21.

6.

PD-1 Blockade in Mediastinal Gray-Zone Lymphoma.

Melani C, Major A, Schowinsky J, Roschewski M, Pittaluga S, Jaffe ES, Pack SD, Abdullaev Z, Ahlman MA, Kwak JJ, Morgan R, Rabinovitch R, Pan Z, Haverkos BM, Gutman JA, Pollyea DA, Smith CA, Wilson WH, Kamdar M.

N Engl J Med. 2017 Jul 6;377(1):89-91. doi: 10.1056/NEJMc1704767. No abstract available.

7.

Changes in allele frequencies of CSF3R and SETBP1 mutations and evidence of clonal evolution in a chronic neutrophilic leukemia patient treated with ruxolitinib.

Nooruddin Z, Miltgen N, Wei Q, Schowinsky J, Pan Z, Tobin J, Purev E, Gutman JA, Robinson W, Pollyea DA.

Haematologica. 2017 May;102(5):e207-e209. doi: 10.3324/haematol.2016.163089. Epub 2017 Feb 16. No abstract available.

8.

Rational design of a parthenolide-based drug regimen that selectively eradicates acute myelogenous leukemia stem cells.

Pei S, Minhajuddin M, D'Alessandro A, Nemkov T, Stevens BM, Adane B, Khan N, Hagen FK, Yadav VK, De S, Ashton JM, Hansen KC, Gutman JA, Pollyea DA, Crooks PA, Smith C, Jordan CT.

J Biol Chem. 2016 Nov 25;291(48):25280. No abstract available.

9.

Rational Design of a Parthenolide-based Drug Regimen That Selectively Eradicates Acute Myelogenous Leukemia Stem Cells.

Pei S, Minhajuddin M, D'Alessandro A, Nemkov T, Stevens BM, Adane B, Khan N, Hagen FK, Yadav VK, De S, Ashton JM, Hansen KC, Gutman JA, Pollyea DA, Crooks PA, Smith C, Jordan CT.

J Biol Chem. 2016 Oct 14;291(42):21984-22000. Epub 2016 Aug 29. Erratum in: J Biol Chem. 2016 Nov 25;291(48):25280.

10.

Programmed Death 1 Expression on CD4+ T Cells Predicts Mortality after Allogeneic Stem Cell Transplantation.

Schade H, Sen S, Neff CP, Freed BM, Gao D, Gutman JA, Palmer BE.

Biol Blood Marrow Transplant. 2016 Dec;22(12):2172-2179. doi: 10.1016/j.bbmt.2016.08.007. Epub 2016 Aug 9.

11.

Chronic graft versus host disease burden and late transplant complications are lower following adult double cord blood versus matched unrelated donor peripheral blood transplantation.

Gutman JA, Ross K, Smith C, Myint H, Lee CK, Salit R, Milano F, Delaney C, Gao D, Pollyea DA.

Bone Marrow Transplant. 2016 Dec;51(12):1588-1593. doi: 10.1038/bmt.2016.186. Epub 2016 Jul 11.

PMID:
27400068
12.

De novo generation of adipocytes from circulating progenitor cells in mouse and human adipose tissue.

Gavin KM, Gutman JA, Kohrt WM, Wei Q, Shea KL, Miller HL, Sullivan TM, Erickson PF, Helm KM, Acosta AS, Childs CR, Musselwhite E, Varella-Garcia M, Kelly K, Majka SM, Klemm DJ.

FASEB J. 2016 Mar;30(3):1096-108. doi: 10.1096/fj.15-278994. Epub 2015 Nov 18.

13.

Clonality of neutrophilia associated with plasma cell neoplasms: report of a SETBP1 mutation and analysis of a single institution series.

Stevens B, Maxson J, Tyner J, Smith CA, Gutman JA, Robinson W, Jordan CT, Lee CK, Swisshelm K, Tobin J, Wei Q, Schowinsky J, Rinella S, Lee HG, Pollyea DA.

Leuk Lymphoma. 2016;57(4):927-34. doi: 10.3109/10428194.2015.1094697. Epub 2015 Oct 27.

14.

Progress toward curing HIV infection with hematopoietic cell transplantation.

Petz LD, Burnett JC, Li H, Li S, Tonai R, Bakalinskaya M, Shpall EJ, Armitage S, Kurtzberg J, Regan DM, Clark P, Querol S, Gutman JA, Spellman SR, Gragert L, Rossi JJ.

Stem Cells Cloning. 2015 Jul 28;8:109-16. doi: 10.2147/SCCAA.S56050. eCollection 2015. Review.

15.

Stopping higher-risk myelodysplastic syndrome in its tracks.

Pollyea DA, Gutman JA.

Curr Hematol Malig Rep. 2014 Dec;9(4):421-31. doi: 10.1007/s11899-014-0234-1. Review.

PMID:
25208927
16.

Targeting acute myeloid leukemia stem cells: a review and principles for the development of clinical trials.

Pollyea DA, Gutman JA, Gore L, Smith CA, Jordan CT.

Haematologica. 2014 Aug;99(8):1277-84. doi: 10.3324/haematol.2013.085209. Review.

17.

Antithrombotic therapy in patients with thrombocytopenic cancer: outcomes associated with reduced-dose, low-molecular-weight heparin during hospitalization.

Babilonia KM, Golightly LK, Gutman JA, Hassell KL, Kaiser JN, Kiser TH, Klem PM, Trujillo TC.

Clin Appl Thromb Hemost. 2014 Nov;20(8):799-806. doi: 10.1177/1076029614543140. Epub 2014 Jul 14.

PMID:
25022565
18.

Omacetaxine mepesuccinate for the treatment of chronic myeloid leukemia.

Narayanan V, Gutman JA, Pollyea DA, Jimeno A.

Drugs Today (Barc). 2013 Jul;49(7):447-56. doi: 10.1358/dot.2013.49.7.1980495. Review.

PMID:
23914353
19.

Ponatinib for the treatment of chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia.

Narayanan V, Pollyea DA, Gutman JA, Jimeno A.

Drugs Today (Barc). 2013 Apr;49(4):261-9. doi: 10.1358/dot.2013.49.4.1950147. Review.

PMID:
23616953
20.

Adjusting DLCO for Hb and its effects on the Hematopoietic Cell Transplantation-specific Comorbidity Index.

Coffey DG, Pollyea DA, Myint H, Smith C, Gutman JA.

Bone Marrow Transplant. 2013 Sep;48(9):1253-6. doi: 10.1038/bmt.2013.31. Epub 2013 Mar 18.

PMID:
23503530
21.

Double umbilical cord blood transplantation in patients with hematologic malignancies using a reduced-intensity preparative regimen without antithymocyte globulin.

Ostronoff F, Milano F, Gooley T, Gutman JA, McSweeney P, Petersen FB, Sandmaier BM, Storb R, Delaney C.

Bone Marrow Transplant. 2013 Jun;48(6):782-6. doi: 10.1038/bmt.2012.243. Epub 2012 Dec 17.

22.

A novel CCAAT/enhancer binding protein α germline variant in a case of acute myeloid leukemia.

Gutman JA, Hoffner B.

Leuk Lymphoma. 2012 May;53(5):1006-7. doi: 10.3109/10428194.2011.638718. Epub 2012 Jan 3. No abstract available.

PMID:
22066712
23.

Stable long-term pulmonary function after myeloablative double cord blood transplant.

Milano F, Chien JW, Riffkin I, Gutman JA, Newell L, Pergam SA, Delaney C.

Biol Blood Marrow Transplant. 2012 Feb;18(2):309-13. doi: 10.1016/j.bbmt.2011.08.008. Epub 2011 Aug 11.

24.

Intensive strategy to prevent CMV disease in seropositive umbilical cord blood transplant recipients.

Milano F, Pergam SA, Xie H, Leisenring WM, Gutman JA, Riffkin I, Chow V, Boeckh MJ, Delaney C.

Blood. 2011 Nov 17;118(20):5689-96. doi: 10.1182/blood-2011-06-361618. Epub 2011 Sep 21.

25.

Cord blood collection after cesarean section improves banking efficiency.

Gutman JA, Miller S, Kuenne S, Oppenheim J, Quinones R, Freed BM, Stark C, Zarlengo G.

Transfusion. 2011 Sep;51(9):2050-1. doi: 10.1111/j.1537-2995.2011.03249.x. No abstract available.

PMID:
21896038
26.

Double unit cord blood transplantation: Who wins-and why do we care?

Gutman JA, Riddell SR, McGoldrick S, Delaney C.

Chimerism. 2010 Jul-Sep;1(1):21-2. doi: 10.4161/chim.1.1.12141.

27.

Allogeneic hematopoietic cell transplantation for hematologic malignancy: relative risks and benefits of double umbilical cord blood.

Brunstein CG, Gutman JA, Weisdorf DJ, Woolfrey AE, Defor TE, Gooley TA, Verneris MR, Appelbaum FR, Wagner JE, Delaney C.

Blood. 2010 Nov 25;116(22):4693-9. doi: 10.1182/blood-2010-05-285304. Epub 2010 Aug 4.

28.

Single-unit dominance after double-unit umbilical cord blood transplantation coincides with a specific CD8+ T-cell response against the nonengrafted unit.

Gutman JA, Turtle CJ, Manley TJ, Heimfeld S, Bernstein ID, Riddell SR, Delaney C.

Blood. 2010 Jan 28;115(4):757-65. doi: 10.1182/blood-2009-07-228999. Epub 2009 Oct 12.

29.

Cord blood transplantation for haematological malignancies: conditioning regimens, double cord transplant and infectious complications.

Delaney C, Gutman JA, Appelbaum FR.

Br J Haematol. 2009 Oct;147(2):207-16. doi: 10.1111/j.1365-2141.2009.07782.x. Review.

PMID:
19796270
30.

Low relapse without excessive transplant-related mortality following myeloablative cord blood transplantation for acute leukemia in complete remission: a matched cohort analysis.

Gutman JA, Leisenring W, Appelbaum FR, Woolfrey AE, Delaney C.

Biol Blood Marrow Transplant. 2009 Sep;15(9):1122-9. doi: 10.1016/j.bbmt.2009.05.014.

31.

Prospective monitoring for alloimmunization in cord blood transplantation: "virtual crossmatch" can be used to demonstrate donor-directed antibodies.

Gutman JA, McKinney SK, Pereira S, Warnock SL, Smith AG, Woolfrey AE, Hansen JA, Delaney C.

Transplantation. 2009 Feb 15;87(3):415-8. doi: 10.1097/TP.0b013e3181943ba3.

32.

Optic nerve sheath diameter correlates with the presence and severity of acute mountain sickness: evidence for increased intracranial pressure.

Fagenholz PJ, Gutman JA, Murray AF, Noble VE, Camargo CA Jr, Harris NS.

J Appl Physiol (1985). 2009 Apr;106(4):1207-11. doi: 10.1152/japplphysiol.01188.2007. Epub 2008 Dec 31.

33.

Pulmonary veno-occlusive disease following reduced-intensity cord blood transplantation.

Gutman JA, Allen CT, Madtes DK, Schramm J, Delaney C.

Bone Marrow Transplant. 2008 Oct;42(8):559-61. doi: 10.1038/bmt.2008.210. Epub 2008 Jul 21. No abstract available.

PMID:
18641679
34.

Arterial thrombosis at high altitude resulting in loss of limb.

Fagenholz PJ, Gutman JA, Murray AF, Noble VE, Wu A, Zeimer G, Harris NS.

High Alt Med Biol. 2007 Winter;8(4):340-7.

PMID:
18081511
35.

Evidence for increased intracranial pressure in high altitude pulmonary edema.

Fagenholz PJ, Gutman JA, Murray AF, Noble VE, Camargo CA Jr, Harris NS.

High Alt Med Biol. 2007 Winter;8(4):331-6.

PMID:
18081509
36.

New-onset anxiety disorders at high altitude.

Fagenholz PJ, Murray AF, Gutman JA, Findley JK, Harris NS.

Wilderness Environ Med. 2007 Winter;18(4):312-6.

PMID:
18076297
37.

Rhinovirus as a cause of fatal lower respiratory tract infection in adult stem cell transplantation patients: a report of two cases.

Gutman JA, Peck AJ, Kuypers J, Boeckh M.

Bone Marrow Transplant. 2007 Oct;40(8):809-11. Epub 2007 Aug 20. No abstract available.

PMID:
17704788
38.

Treatment of high altitude pulmonary edema at 4240 m in Nepal.

Fagenholz PJ, Gutman JA, Murray AF, Harris NS.

High Alt Med Biol. 2007 Summer;8(2):139-46.

PMID:
17584008
39.

Chest ultrasonography for the diagnosis and monitoring of high-altitude pulmonary edema.

Fagenholz PJ, Gutman JA, Murray AF, Noble VE, Thomas SH, Harris NS.

Chest. 2007 Apr;131(4):1013-8.

PMID:
17426204
40.

Autologous transplantation followed closely by reduced-intensity allogeneic transplantation as consolidative immunotherapy in advanced lymphoma patients: a feasibility study.

Gutman JA, Bearman SI, Nieto Y, Sweetenham JW, Jones RB, Shpall EJ, Zeng C, Baron A, McSweeney PA.

Bone Marrow Transplant. 2005 Sep;36(5):443-51.

PMID:
15995712
41.

A 50-year-old man with skin lesions and multiple pulmonary nodules.

Olson AL, Gutman JA, Welsh CH.

Chest. 2004 Jun;125(6):2322-7. No abstract available.

PMID:
15189957
42.

Disopyramide-induced heart block.

Timins BI, Gutman JA, Haft JI.

Chest. 1981 Apr;79(4):477-9.

PMID:
7226916
43.

Atrial fibrillation in the Wolff-Parkinson-White syndrome.

Gutman JA, Haft JI.

J Med Soc N J. 1979 Dec;76(13):907-12. No abstract available.

PMID:
292797
44.

Chronic chest pain and dyspnea caused by occult constrictive pericarditis.

Gutman JA, Haft JI.

J Med Soc N J. 1979 Jul;76(7):517-20. No abstract available.

PMID:
289850
45.

Mediastinal tumor presenting as a new heart murmur: diagnosis and treatment.

Gutman JA, Haft JI.

J Med Soc N J. 1979 May;76(5):364-6. No abstract available.

PMID:
286810

Supplemental Content

Loading ...
Support Center